Clinical trials
Active, not recruiting Myelodysplastic Syndromes trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 3 |
| Novartis Pharmaceuticals | 2 |
| AbbVie | 1 |
| Agios Pharmaceuticals, Inc. | 1 |
| Associazione Qol-one | 1 |
| Bellicum Pharmaceuticals | 1 |
| Celgene | 1 |
| Fondazione Italiana Sindromi Mielodisplastiche-ETS | 1 |
| Geron Corporation | 1 |
| Groupe Francophone des Myelodysplasies | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 15 |
| Anemia | 5 |
| Thrombocytopenia | 3 |
| Anemia, Refractory, with Excess of Blasts | 2 |
| Leukemia, Myeloid, Acute | 2 |
| Leukemia, Myelomonocytic, Chronic | 2 |
| Recurrence | 2 |
| Hematologic Neoplasms | 1 |
| Leukemia | 1 |
| Lymphoma | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.